(AOF) – Arkema revealed degraded 2023 results in a context of weak demand. The chemical group’s current net profit fell 44% to 653 million euros. Ebitda fell 28.9% to 1.501 billion euros. The Ebitda margin fell to 15.8% compared to 18.3% in 2022. Turnover at 9.5 billion euros was down 16.1% at constant exchange rates and scope. It was penalized by falling prices and volumes.
The chemical group is proposing a dividend of 3.50 euros per share (3.40 euros in 2022), in line with the progressive growth policy and corresponding to a distribution rate of 40%.
This year, Arkema expects Ebitda to increase between 1.5 billion and 1.7 billion euros. “The start of the year should be a continuation of the weak demand in the fourth quarter of 2023,” warns the group. Ebitda growth should be focused mainly on the second part of the year with the ramp-up of the main growth projects from the second quarter and a gradual improvement in market conditions.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
